Fulcrum Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Fulcrum Pharmaceuticals Inc. is using its proprietary insights into thermodynamics as a platform technology for rapidly designing thermodynamically optimized lead compounds for drug discovery.
You may also be interested in...
New Drugs for Osteoporosis
Significant increases in the drug-treated patient population are pushing start-ups to pursue novel mechanisms of action for treating osteoporosis.
With A New CSO, Bristol-Myers Squibb Doubles Down On Immuno-Oncology
BMS’ strategy for the complex, highly competitive immuno-oncology field. A Q&A with the company’s new R&D chief, lung cancer specialist Thomas Lynch, MD.
Patheon Tightens The Supply Chain To Transform Pharma Outsource Manufacturing
Fueled by a series of strategic acquisitions, Patheon hopes to become the biopharma industry’s first single-source, end-to-end manufacturing service provider.